Henry Ford Health Clinical Insights

• As Michigan’s most comprehensive transplant program, Henry Ford Transplant offers transplantation of the liver, kidney, pancreas, intestine and multivisceral organs, heart, lung, and bone marrow stem cell. The Institute is always on the forefront of transplantation science and performs the most advanced minimally invasive procedures and living organ donations for liver and kidney transplants. Our commitment to quality leads to outcomes that meet or exceed expected survival rates. We use the most effective clinical strategies to increase transplant rates while maintaining superior patient outcomes.
• In 2025, Henry Ford Health performed:
  • 175 adult liver transplants - 44 more than the previous Michigan record and continuing our two-decade streak as the state’s largest adult program
  • 6 pediatric liver transplants in collaboration with Children's Hospital of Michigan
  • 16 combined liver-kidney transplants - the most ever in Michigan
  • 4 intestinal transplants – we have the only intestinal transplant program in the state
  • 2 combined liver/intestine/pancreas transplants
  • 144 kidney transplants - the most ever in Metro Detroit
• Henry Ford is also the only center in Michigan performing lung-liver transplants, and the only program actively performing heart-liver transplants.
• We performed our state’s second beating heart transplant in 2024. Since that time, he and his team have performed four more. Among many benefits, a beating heart transplant allows the team to receive donor hearts from greater distances.

• Henry Ford Health is blazing the way in our region and the nation in the development and growth of Precision Medicine, a wide-ranging DNA-inspired approach to advance and enhance care in many specialties. Precision Medicine is the practice of using data, including, for example, each patient’s genes, environment and lifestyle factors to risk stratify and tailor the treatment.
• Our Complex Surgical Oncology team recently launched its Hepatic Arterial Infusion (HAI) program – one of only two in Michigan. This program offers an option for patients with liver-dominant advanced cancers that otherwise do not have meaningful treatment options.
• Henry Ford Macomb Hospital made history in 2025 with a world-first usage of an AI-powered navigation system during an operation to remove lung nodules in a patient. They used the MONARCH robotic bronchoscopy platform with MONARCH™ QUEST, which uses AI to assist with navigation, allowing for improved precision in targeting lung nodules.
• We performed a Single-Port (SP) robotic lung cancer resection, the first procedure of its kind in Michigan and one of only a handful performed throughout the country. Unlike the traditional multi-port Da Vinci robotic system, the SP platform requires only a single small incision, which translates into less pain, faster recovery, and minimal scarring for patients. The system offers enhanced precision, improved control, and a magnified 3D view – features that enable us to perform complex thoracic procedures with greater dexterity and reduced tissue trauma.

Learn more about Henry Ford Health’s achievements in Cancer care

• The Henry Ford Advanced Therapeutic Endoscopy group, in collaboration with Surgical Oncology, has recently incorporated endoscopic ultrasound (EUS)–guided, needle-based confocal laser endomicroscopy (nCLE) into its standard clinical workflow for the evaluation of pancreatic cystic lesions. This advanced imaging technology is offered by only a few centers nationwide. This group is also participating in an ongoing national multicenter clinical trial (CLIMB study), which seeks to further evaluate the accuracy and safety of this technology and to advance diagnostic strategies for pancreatic cystic lesions nationwide.
• We have become the first in the state of Michigan to offer intestinal ultrasound (IUS) to patients with inflammatory bowel disease. This point-of-care, non-invasive imaging modality allows for real-time assessment of intestinal inflammation without the need for radiation or bowel prep. Intestinal ultrasound enhances our ability to make timely treatment decisions and improves patient experience, especially in longitudinal monitoring of Crohn’s disease and ulcerative colitis.
• In 2025, Henry Ford Health opened our new main campus endoscopy unit. At over 24,000 square feet and housing 11 state-of-the-art endoscopy rooms, this is believed to be the largest single hospital-based endoscopy unit in the nation and offers world-class technology to thousands of patients annually. Perhaps most importantly, it is firmly planted in the heart of the city of Detroit- bringing the most complex care home to patients who truly need it.
• We are the first in the state of Michigan to offer the following comprehensive and multidisciplinary programs:
  • Ablative procedures to treat cancers involving the bile duct
  • Advanced procedures to non-invasively diagnose cirrhosis and mitigate vascular complications of this condition
  • Stricturotomy to treat complex luminal narrowing throughout the GI tract

• The cardiac surgery program at Henry Ford Hospital has been awarded the prestigious “3 Star Rating” for coronary bypass by the Society of Thoracic Surgeons (STS) for the time period ending June 2025. Nationally, only 10-15% of heart centers attain the STS three-star designation, which recognizes quality and clinical excellence.
• The cardiovascular team at Henry Ford Rochester Hospital completed an implant of a first-of-its-kind extravascular defibrillator on a 37-year-old patient who had sustained VT and cardiac arrest. The Aurora EV-ICD™ system treats sudden cardiac arrest and abnormal heart rhythms with defibrillation and antitachycardia pacing (ATP) in a single device. It is the only ICD placed outside the vascular space that provides ATP in a single device and is nearly half the size with 60% greater projected battery longevity than the subcutaneous implantable cardioverter defibrillator (S-ICD).
• A patient at Henry Ford Hospital received one of the first BrioVADs in the country. This implant is possible at only seven chosen centers across the U.S., as part of the Innovate Trial. This new pump is intended to support patients with end stage heart failure or recalcitrant cardiogenic shock, allowing discharge to home and survival that is up to 500 times better than that of medical management alone.
• Henry Ford cardiologists were first in the U.S. and second in the world to implant an intraaortic axial flow pump that is being investigated in a clinical trial for patients hospitalized with acute decompensated heart failure and worsening kidney function.

Learn more about Henry Ford Health’s achievements in Heart & Vascular care

• Our adoption of RapidAI, a platform that can accelerate stroke diagnosis and treatment, recently earned us a spotlight in the AMA news. This is an augmented intelligence (AI) tool that analyzes CT scans for large vessel occlusion and instantly sends images and notifications to clinicians’ mobile devices. This technology allows our team to respond immediately and with the appropriate level of care.
• We were the first in Michigan to use the adaptive Deep Brain Stimulation (aDBS) technology. This delivers constant stimulation to help control brain stimulation resulting in involuntary movement such as in Parkinson’s Disease, essential tremors (ET) or cervical dystonia.
• We performed a first-in-the-world procedure to implant Cs-131 radiation seeds (Gamma Tile) into the spine of a patient with recurrent and progressive colorectal cancer. With the support of Henry Ford Innovations, the team 3D-printed the patient’s anatomy to model the procedure and radiation plans. The success of this innovative approach has the potential to pave the way for future advancements in the treatment of spinal metastases.
• The Henry Ford Movement Disorders Center at Henry Ford Hospital has been nationally recognized as an HDSA Center of Excellence. With this recognition, the team at Henry Ford Hospital will receive a financial award to channel into its care and services for those they serve in the community with Huntington’s Disease.

Learn more about Henry Ford Health’s achievements in Neurology & Neurosurgery care

• Henry Ford Hospital has been recognized as a Best Hospital for 2024-25 in the Ear, Nose & Throat specialty by U.S. News & World Report, which features the top 50 of America’s “Best Hospitals” in 15 specialties.
• In 2022, the Skull Base team at Henry Ford Hospital in Detroit earned a Multidisciplinary Team of Distinction designation from the North American Skull Base Society (NASBS), which recognizes NASBS member institutions that have skull base surgery teams comprising physicians in a variety of specialties and disciplines. Henry Ford’s Skull Base team was one of only two in Michigan, and one of only 38 total, to receive the Team of Distinction.
• Researchers from Henry Ford Health + Michigan State University Health Sciences have been awarded a $3 million grant from the National Institute of Dental and Craniofacial Research to study new treatments for patients who have head and neck cancer caused by the human papillomavirus, or HPV.
• Henry Ford Health is in the top 10th percentile for time of initiation of postoperative radiation therapy for head and neck cancer patients (< 6 weeks).

• The American College of Surgeons (ACS) selected Henry Ford Hospital for Achieving Meritorious Outcomes for Surgical Patient Care. Hospital surgical outcomes were categorized in two ways – All Cases Meritorious and High-Risk Meritorious. Henry Ford Hospital was among only 39 hospitals recognized in both categories and was the only hospital in Michigan to make this prestigious list, which was selected as part of the ACS National Surgical Quality Improvement Program (NSQIP).
• Four Henry Ford Health hospitals (Henry Ford Hospital in Detroit, Henry Ford Jackson Hospital, Henry Ford Providence Novi Hospital, and Henry Ford West Bloomfield Hospital) received ‘A’ ratings for safety by the Leapfrog Group – the most for any hospital system in the state.
• Henry Ford Health earned national distinction with the American Medical Association’s Joy in Medicine® Award, honoring healthcare organizations that prioritize proven methods to reduce burnout and enhance the professional fulfillment of doctors that comes from patient care.
• We were named the American Medical Group Association’s 2025 Acclaim Award recipient. The Acclaim Award honors healthcare delivery organizations that are bringing the American healthcare system closer to the ideal delivery model – one that is safe, effective, patient-centered, timely, efficient, and equitable.

Learn more about Henry Ford Health’s achievements in Quality & Safety

• We recently performed the US’s second bilateral renal artery denervation procedure for refractory hypotension. We are the first in the world to complete this procedure with the single-port robot using a single positioning to expedite the bilateral procedure. We used an investigational ablation device as part of a trial with six centers and in partnership with the Heart & Vascular Institute. The patient had poorly controlled hypertension refractory to multiple medications with no other options. The patient’s systolic blood pressure at the beginning of the surgery was 210 and dropped to the mid-90s after the procedure.
• In 2023, Henry Ford Health was the first health system in Michigan to offer ExactVu, a cutting-edge technology for diagnosing and evaluating prostate cancer. Enhancing the precision and speed of diagnosis, this new technology ensures patients receive timely and appropriate care, while also providing a more efficient and convenient experience than other diagnostic methods.
• In 2021, surgeons at the Henry Ford Health Vattikuti Urology Institute (VUI) performed the world's first precision prostatectomy through the bladder using a single port robotic surgical system.
• Our urology team at Henry Ford West Bloomfield Hospital recently completed its first Aquablation therapy procedure, expanding access to an innovative, minimally invasive treatment option to men with benign prostatic hyperplasia (BPH), a non-cancerous enlargement of the prostate gland. This milestone makes West Bloomfield the first Henry Ford Health location - and one of only a few in Michigan - to offer Aquablation therapy.

Learn more about Henry Ford Health’s achievements in Urology care